Vilazodone hydrochloride tablets and empagliflozin tablets had a market value of $469 million and roughly $3.4 billion respectively, for the 12 months ended September 2019.
Drug pricing and reimbursement constraints will have the greatest negative impact on the pharmaceutical industry in 2020, according to a new report from data and analytics company GlobalData.
CVS Health is providing support to patients in Puerto Rico impacted by recent earthquakes, including advance prescription benefits and product donations.
Arizona, Connecticut and Massachusetts pharmacy associations are receiving PTCB project grants focused on training pharmacy technicians on methods to address the opioid crisis.
Valtoco is the first nasal spray approved by the Food and Drug Administration as a rescue treatment for people with epilepsy age 6 years old and older.
The new guidelines require aspiring certified pharmacy technicians to complete the PTCB-recognized education/training program or have equivalent work experience before they take the Pharmacy Technician Certification Exam.
Fifteen HealthHub locations in Houston will offer expanded healthcare services, chronic disease management and overall health and wellness advice and personalized care.
The United States Supreme Court this spring will review a case with big implications for the pharmacy world.
The court has agreed to hear oral arguments in Rutledge v.
Innovation has announced its new leadership on the heels of the recent closing of the transaction in which a consortium of investors, led by Greg Wasson, the former Walgreens Boots Alliance CEO, acquired a majority stake in the company.
The MedCerts newly enhanced program now features expanded customer service training, which has been identified by employers as the most in demand “soft skills” for technicians.
Enhertu is indicated for the treatment of patients with unresectable or metastatic HER2-positive breast cancer who have received two or more prior anti-HER2-based regimens.
Twenty-nine of the 48 novel drug approvals of 2019, or 60%, were designated in one or more expedited categories of Fast Track, Breakthrough, Priority Review, and/or Accelerated Approval.
Alembic's generic Temovate provides a short-term topical treatment of inflammatory and pruritic manifestations of moderate to severe corticosteroid-responsive dermatoses of the scalp.
Venlafaxine ER tablets, 150 mg and 225 mg, and lidocaine topical solution 4% had a market value of roughly $150 million and $17 million, respectively, for the 12 months ended November 2019.
Genoa Healthcare’s 500th pharmacy, located within the Catholic Charities Behavioral Health Center in Queens, N.Y., will serve approximately 2,000 patients.
Publix — DSN's 2019 Pharmacy Innovator of the Year — has built a specialty operation that executives said has improved its ability to care for patients on specialty therapies, as well as access to limited-distribution drugs.
CVS Health, Walgreens, and Rite Aid have donated their dispensing services for HIV PrEP medications to the Department of Health and Human Services and its new Ready, Set, PrEP program.
The FDA has approved three applications for first generics of Novartis’ Gilenya (fingolimod) capsules for relapsing forms of multiple sclerosis in adult patients.
Exjade had a market value of roughly $113 million and Jadenu had a market value of about $470 million for the most recent 12 months ended in September.
Amneal has received the Food and Drug Administration’s clearance for three generics that it is introducing immediately, including the first generic of Carafate (sucralfate oral suspension).
